基于家庭的肺部康复对后COVID-19患者的运动能力的影响:一个随机控制的跟踪
Tamer I Abo Elyazed1, Laila A Alsharawy2, Shaimaa E Salem3,4
1Department of Physical Therapy for Internal Medicine, Faculty of Physical Therapy, Beni-Suef University, Beni Suef, Egypt. tamer.i.aboelyazed@gmail.com.
Journal of neuroengineering and rehabilitation
|March 26, 2024
概括
在家进行的肺部康复治疗显著改善了COVID-19综合征后患者的运动能力,并减少了疲劳和呼吸障碍. 这种可访问的疗法为长期康复和改善生活质量提供了低成本的解决方案.
科学领域:
- 肺部康复治疗 肺部康复治疗
- 在COVID-19研究研究中.
- 临床试验 临床试验
背景情况:
- 后COVID-19综合征表现为持续的疲劳,呼吸障碍和运动不耐受.
- 有效的康复策略对于管理COVID-19的长期后果至关重要.
研究的目的:
- 评估在COVID-19后综合征患者的运动能力上基于家庭的肺部康复 (HBPR) 的疗效.
- 评估HBPR对疲劳,呼吸障碍和生活质量的影响.
主要方法:
- 随机对照试验涉及68名患者 (40-70岁) 患有COVID-19后综合征.
- 干预组在常规护理中接受HBPR;对照组仅接受常规护理.
- 评估结果包括6分钟步行测试 (6MWT),Chalder疲劳指数,SF-36,以及超过12周的呼吸障碍尺度.
主要成果:
- 与对照组相比,HBPR组表现出明显较低的疲劳分数和更高的6MWT和SF-36分数.
- 在HBPR组中观察到呼吸障碍的显著改善 (p < 0.001).
- 在干预组中,HBPR导致身体健康指数 (PFI) 提高.
结论:
- 基于家庭的肺部康复是后COVID-19综合征的有效辅助疗法.
- HBPR对运动能力,疲劳,呼吸障碍和生活质量产生积极影响.
- HBPR为长期的COVID-19康复提供了一种实用,低成本的治疗选择.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
202
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
202
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
206
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
206
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
269
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
269


